Research study Program year 2024 Source: CMS Open Payments

Tarlatamab 20200469

Research payments

$8,961,774

48 payments

Through program year 2024, $8,961,774 in research payments was reported against Tarlatamab 20200469, across 48 payments, paid by Amgen Inc..

Paid by
Amgen Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2024 Research $8,679,986 24
2023 Research $278,881 16
2022 Research $2,907 8

Breakdown

Who paid Research payments · program years 2022–2024
  1. Amgen Inc. $8,961,774 48 payments
Who received the money Research payments · program years 2022–2024
  1. New York University Grossman School Of Medicine And New York University Langone Hospitals Organisation paid for research $5,246,868 2 payments
  2. Swedish Medical Center Teaching hospital · WA $1,762,345 2 payments
  3. University Of Southern California Norris Comprehensive Cancer Center Organisation paid for research $465,786 2 payments
  4. Avera Mckennan Teaching hospital · SD $444,745 2 payments
  5. Rutgers Cancer Institute Of New Jersey Organisation paid for research $415,708 3 payments
  6. The University Of North Carolina At Chapel Hill Organisation paid for research $310,619 2 payments
  7. The University Of North Carolina Ch Lineberger Comprehenisve Cancer Ctr Organisation paid for research $63,031 2 payments
  8. Ny Univ Langone Med Ctr Organisation paid for research $28,116 1 payment
  9. Swedish Health Services Organisation paid for research $26,926 1 payment
  10. Rutgers The State University Organisation paid for research $26,443 1 payment

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record